Navigation Links
Venaxis Advances Pivotal U.S. Study and Accelerates European Market Development for APPY1 Blood-based Appendicitis Test
Date:3/26/2013

60;

A telephonic replay of the call will be available for 30 days beginning at 8:00 p.m. ET on March 26, 2013.  Access numbers for this replay are 1-877-344-7529 (U.S./Canada) and 1-412-317-0088 (international); conference ID: 10026445.  The webcast replay will remain available in the Investors Relations section of the Venaxis web site for 30 days.

About Venaxis, Inc.
Venaxis, Inc. is an in vitro diagnostic company focused on the clinical development and commercialization of its rapid, protein biomarker-based appendicitis test, APPY1.  This unique appendicitis test has projected high sensitivity and negative predictive value and is being developed to aid in the identification of patients at low risk for acute appendicitis, allowing for more conservative patient management.  APPY1 is CE Marked in Europe and is being developed in the U.S. initially for pediatric, adolescent and young adult patients with abdominal pain, as this population is at the highest risk for appendicitis and has the highest risk of long-term health effects associated with CT imaging.  While FDA clearance is being sought, an initial launch for APPY1 is ongoing in select European territories.  For more information, visit www.venaxis.com.

Forward-Looking Statements
This press release includes "forward-looking statements" of Venaxis, Inc. ("Venaxis") as defined by the Securities and Exchange Commission ("SEC"). All statements, other than statements of historical fact, included in this press release that address activities, events or developments that Venaxis believes or anticipates will or may occur in the future are forward-looking statements. These statements are based on certain assumptions made based on experience, expected future developments and other factors Venaxis believes are appropriate in the circumstances. Such
'/>"/>

SOURCE Venaxis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AspenBio Pharma Changes Company Name to Venaxis, Inc.
2. Venaxis to Present at 2013 BIO CEO and Investor Conference
3. Venaxis Presentation Rescheduled for 2013 BIO CEO and Investor Conference
4. Venaxis to Present at 25th Annual ROTH Conference
5. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
6. Selexis Lubris Partnership Advances Difficult-to-Express Protein Towards Clinic
7. Medical Imaging Information Systems Market to 2017 - Replacement of Legacy Systems and Advances in Software Present Growth Opportunities
8. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
9. URAC sets standards for community pharmacy, advances dialogue about pharmacists as medication experts
10. Neurostimulation Devices Market to 2018 - Technological Advances and Robust Pipeline with Multi-Indication Potential and Non-Invasive Therapies to Drive Growth
11. Pharmaceutical Supply Chain in the US - Advances in RFID and ePedigree Systems to Limit Drug Counterfeits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... 21, 2014  Zacks.com announces the list of stocks featured ... analysts discuss the latest news and events impacting stocks and ... Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH - Free Report ), ... Lilly and Company (NYSE: LLY - Free Report ), ... Inc. (Nasdaq: ITMN - Free Report ). ...
(Date:7/21/2014)... Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... treatments for cancer and its associated pain, today announced ... development of a small molecule inhibitor targeting the important ... protein has also been recognized as an important determinant ... as a dominant factor in most human cancers and ...
(Date:7/21/2014)...  A new Journal of the American Medical ... to appear in the August 13 print edition addresses ... C Virus (HCV) treatments such as Sovaldi (sofosbuvir) and ... (NYSE: CVS ) Chief Medical Officer Troyen ... Shrank , M.D., suggest that the discussion to this ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 2The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 3The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 4The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 5The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 6The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 7Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 2Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 3Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 4CVS Caremark JAMA Commentary: New Hepatitis C Treatments Highlight Need to Control Costs of High-Priced Specialty Medications 2CVS Caremark JAMA Commentary: New Hepatitis C Treatments Highlight Need to Control Costs of High-Priced Specialty Medications 3
... INDIANAPOLIS and ROLLING MEADOWS, Ill., April 4, 2012 ... the Diabetes Scholars Foundation (Foundation) scholarship fund. The contribution ... with type 1 diabetes to live their lives to ... fund college scholarships for students with type 1 diabetes ...
... 2012   Sunpeaks Ventures, Inc. (OTCBB: SNPK) ... its wholly owned subsidiary Healthcare Distribution Specialists, LLC ... has entered into an Agreement with Albeck Financial ... Albeck will provide outsourced Chief Financial Officer services, ...
Cached Medicine Technology:Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012 2Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012 3Sunpeaks Ventures Announces Agreement with Albeck Financial Services 2
(Date:7/22/2014)... (PRWEB) July 22, 2014 The ... (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin ... Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast ... major drivers, restraints, challenges, opportunities, current market trends, ... along with the estimates and forecasts of the ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 For more ... and cold storage consumers with dynamic, specialized ... and customer satisfaction. Offering 50-70% less energy requirements ... process. This process is completed through a non-chemical ... technologies also provide a 4.2 Micron droplet. The ...
(Date:7/22/2014)... Rockville, Maryland (PRWEB) July 22, 2014 ... partnership with the Immune Deficiency Foundation (IDF) ... and mobile portal that will allow them to electronically ... to better manage their illnesses. It will also allow ... in research, to consent to have their data ...
(Date:7/22/2014)... Altec Products, Inc. , a ... today their Gold Sponsorship of Sage Summit 2014 ... Hotel and Casino in Las Vegas, Nevada. The largest ... interested in taking advantage of the many opportunities to ... problems and educate themselves on the latest enterprise resource ...
(Date:7/22/2014)... Tigrent Learning Canada today announced ... estate investing workshops being held in the greater Toronto, ... introduce people to some of the strategies successful investors ... total of 9 free real estate investing workshops will ... goal is to give people in the greater Toronto ...
Breaking Medicine News(10 mins):Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 5Health News:Smart Fog Inc Announces Cold Storage Humidification Technology to be Exhibited at the 2014 Fresh Summit Convention & Expo 2Health News:Smart Fog Inc Announces Cold Storage Humidification Technology to be Exhibited at the 2014 Fresh Summit Convention & Expo 3Health News:Get Real Health to Partner with Immune Deficiency Foundation 2Health News:Get Real Health to Partner with Immune Deficiency Foundation 3Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 3Health News:Brick Buy Brick Announces Multiple 1-Day Real Estate Workshops Coming to Toronto 2
... of their breasts, can breathe easy now. They can raise ... their photographs . ,Visit www.myFreeimplants.com, set up a ... with other members. ,Once you have uploaded their ... can have a one-on-one chat online with benefactors and sell ...
... pair of legs in show business . ,But a ... hottest legs. ,Girls Aloud singer Nadine Coyle was voted ... ,The English all-girl group member beat other long-legged ladies ... singer Beyonce Knowles bagged the second place while troubled pop star ...
... Actor/producer Kirk Douglas admits that when it came to beautiful women ... ,The 90-year-old revealed that when he was young he ... with her. ,"The young Kirk was too interested in ... Post quoted Douglas, as saying. ,The actor revealed that ...
... law to ban circuses from importing or exporting protected ... rights, a legislator said Friday . ,Under ... imports and exports of animals such as lions, tigers, ... for research, said Tien Chiu-chin, of the ruling Democratic ...
... and money to properly treat a growing number of ... report out Friday . ,"The military system ... adequately support the psychological health of service members and ... year-long Pentagon mental health task force report: "An Achievable ...
... year in Sierra Leone's capital Freetown last year has been ... health worker attributed the fall in rabies cases to a ... the main referral Connaught Hospital are worried about a lack ... hospital has had to rely heavily on anti-rabies drug handouts ...
Cached Medicine News:Health News:Website Offers to Help Women Raise Money for Breast Enhancement 2Health News:War Veterans Lack Adequate Mental Health Care: Pentagon Report 2
... LV lead is designed to ensure ... procedure times, delivering a complete package ... QuickSite LV lead is a highly ... including such features as S-shaped fixation, ...
... Tibial Nail System is designed ... of existing implants and expand ... nails. It is available in ... and lengths and can be ...
Arthroscopic instrument system for instability and SLAP fixation....
Arthroscopic instrument system for instability and SLAP fixation....
Medicine Products: